Walleye Capital’s Satsuma Pharmaceuticals STSA Stock Holding History
Bought
Maintained
Sold
Other funds holding STSA
BCM
Walleye Capital's STSA Position: Q4 2022 in Review
Walleye Capital sold out of Satsuma Pharmaceuticals (STSA) in Q4 2022, closing a stake of 93,672 shares — an estimated $562K sold.
Walleye Capital first reported a position in STSA in Q1 2022 and held it in 3 quarters. The position peaked at $995K in Q1 2022. 33 funds tracked by Wall St. Rank hold STSA as of Q4 2022.
- Walleye Capital reported no remaining Satsuma Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Walleye Capital sold 93,672 Satsuma Pharmaceuticals shares in Q4 2022, an estimated $562K.
- Walleye Capital first reported a position in Satsuma Pharmaceuticals in Q1 2022 and held it in 3 quarters.
- Walleye Capital's Satsuma Pharmaceuticals position peaked at $995K in Q1 2022.
- 33 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q4 2022.
Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.